What Happened?
Kolmar Korea held an IR session on August 27, 2025, as part of the UBS Korea Beauty Entertainment Tour. The company presented its Q2 2025 earnings and key management updates, followed by a Q&A session.
IR Analysis: Key Takeaways and Their Significance
1. Solid Earnings Growth: Kolmar Korea reported revenue of KRW 1.38 trillion and operating profit of KRW 133.4 billion in the first half of 2025, both showing year-over-year growth. This growth was driven by strengthened global competitiveness in the cosmetics ODM sector and the growth of HK innoN’s pharmaceuticals and H&B businesses.
2. Positive Future Growth Drivers: Kolmar Korea continues to invest in future growth through eco-friendly technology development, securing new drug pipelines, and pursuing KOSDAQ listing. AI skin diagnosis technology and eco-friendly material development are expected to be long-term growth drivers.
3. Global Investment Attraction Opportunity: Participation in the UBS Korea Beauty Entertainment Tour provided Kolmar Korea with a valuable opportunity to showcase its growth potential to global investors.
What’s Next? Investment Strategy
While Kolmar Korea presents attractive investment potential, investors should consider several risk factors, including:
- Potential global economic downturn
- Volatility in raw material prices and exchange rates
- Intensifying competition
Careful analysis of these external factors alongside the information presented in the IR is crucial for making informed investment decisions. Specifically, investors should focus on the sustainability of earnings improvement, the performance of new businesses, and the overall impact of changes in the macroeconomic environment. A long-term investment perspective is recommended.